American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 322-329.e1 , 1 February 2010

Prognostic Factors of Vitreous Hemorrhage Secondary to Exudative Age-Related Macular Degeneration

,Accepted 16 September 2009.

References 

  1. el Baba F, Jarrett WH, Harbin TS, et al. Massive hemorrhage complicating age-related macular degeneration (Clinicopathologic correlation and role of anticoagulants). Ophthalmology. 1986;93:1581–1592
  2. Googe JM, Hirose T, Apple DJ, Melgen S. Vitreous hemorrhage secondary to age-related macular degeneration. Surv Ophthalmol. 1987;32:123–130
  3. Azzolini C, Menchini U, Pece A, Camesasca F, Giuliani V. Age-related macular degeneration and vitreous hemorrhage. Eur J Ophthalmol. 1991;1:142–147
  4. de Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 1988;105:25–29
  5. Gomi F, Emi K, Motokura M, Oshima Y, Yamanishi S. [Long-term results after simple vitrectomy for age-related macular degeneration with vitreous hemorrhage]. Nippon Ganka Gakkai Zasshi. 1998;102:436–441
  6. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900–1906discussion 1906–1907
  7. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study. Can J Ophthalmol. 1999;34:385–388
  8. Ojima Y, Tsujikawa A, Otani A, Hirami Y, Aikawa H, Yoshimura N. Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2006;141:958–960
  9. Hirami Y, Tsujikawa A, Otani A, et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina. 2007;27:335–341
  10. Kleiner RC, Brucker AJ, Johnston RL. The posterior uveal bleeding syndrome. Retina. 1990;10:9–17
  11. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1–8
  12. Uyama M, Matsubara T, Fukushima I, et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol. 1999;117:1035–1042
  13. Tilanus MA, Vaandrager W, Cuypers MH, Verbeek AM, Hoyng CB. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2000;238:482–485
  14. Kurashige Y, Otani A, Sasahara M, et al. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2008;146:513–519
  15. Yodoi Y, Sasahara M, Kameda T, Yoshimura N, Otani A. Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:5464–5472
  16. Uyama M, Takahashi K, Ida N, et al. The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol. 2000;84:1018–1023
  17. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15–22
  18. Chen H, Yang Z, Gibbs D, et al. Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration. Vision Res. 2008;48:690–694
  19. Gotoh N, Yamada R, Nakanishi H, et al. Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Experiment Ophthalmol. 2008;36:437–442
  20. Sakurada Y, Kubota T, Mabuchi F, Imasawa M, Tanabe N, Iijima H. Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2008;145:1058–1062

PII: S0002-9394(09)00725-9

doi: 10.1016/j.ajo.2009.09.012

American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 322-329.e1 , 1 February 2010

Article Tools

* Image Usage & Resolution